Oscar Health (NYSE:OSCR) CFO Richard Scott Blackley Sells 31,683 Shares

Oscar Health, Inc. (NYSE:OSCR) CFO Richard Scott Blackley sold 31,683 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $695,125.02. Following the completion of the sale, the chief financial officer owned 1,074,977 shares of the company’s stock, valued at $23,584,995.38. This trade represents a 2.86% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Richard Scott Blackley also recently made the following trade(s):

• On Thursday, May 14th, Richard Scott Blackley sold 100,000 shares of Oscar Health stock. The shares were sold at an average price of $23.16, for a total transaction of $2,316,000.00.

Oscar Health Stock Performance

Shares of OSCR opened at $23.54 on Friday. The company has a 50-day simple moving average of $18.15 and a 200-day simple moving average of $16.00. The company has a quick ratio of 1.11, a current ratio of 1.11 and a debt-to-equity ratio of 0.26. The company has a market capitalization of $7.10 billion, a PE ratio of -39.90, a P/E/G ratio of 1.43 and a beta of 2.37. Oscar Health, Inc. has a 52-week low of $10.69 and a 52-week high of $25.58.

Oscar Health (NYSE:OSCR) last announced its quarterly earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.11 by $0.96. The business had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.90 billion. Oscar Health had a negative net margin of 0.30% and a negative return on equity of 3.26%. The business’s revenue was up 52.6% compared to the same quarter last year. During the same quarter last year, the firm posted $0.92 EPS. Equities research analysts predict that Oscar Health, Inc. will post 0.47 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on OSCR. Wells Fargo & Company set a $20.00 price target on shares of Oscar Health and gave the company an “equal weight” rating in a report on Thursday. Raymond James Financial upgraded shares of Oscar Health from a “market perform” rating to an “outperform” rating and set a $18.00 target price for the company in a report on Thursday, February 12th. Zacks Research upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Thursday, May 7th. Weiss Ratings restated a “sell (d)” rating on shares of Oscar Health in a report on Tuesday, April 21st. Finally, Wall Street Zen upgraded shares of Oscar Health from a “hold” rating to a “strong-buy” rating in a report on Saturday, May 9th. One equities research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating, eight have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Oscar Health presently has an average rating of “Hold” and a consensus price target of $20.22.

Key Headlines Impacting Oscar Health

Here are the key news stories impacting Oscar Health this week:

• Positive Sentiment: Wells Fargo upgraded Oscar Health from “strong sell” to “hold”, suggesting the worst of the downside may be behind the stock even though the new $20 target still sits below the current share price. Zacks.com
• Positive Sentiment: A news item that Oscar Health co-founder is shifting into an advisory leadership role appears to be an internal transition rather than a disruptive change, which may be viewed as manageable by investors. Oscar Health Co-Founder Shifts to Advisory Leadership Role
• Neutral Sentiment: Oscar Health reported strong first-quarter EPS of $2.07, beating estimates by a wide margin, though revenue came in below expectations. The earnings beat supports the company’s fundamentals, but the softer revenue print limits the upside reaction.
• Neutral Sentiment: Multiple insiders, including CFO Richard Scott Blackley, Janet Liang, Adam Mcananey, Director Mario Schlosser, and CAO Victoria Baltrus, sold shares under pre-arranged 10b5-1 plans to cover tax withholding on vested equity awards. Because these were scheduled transactions, they are less alarming than discretionary selling, but the cluster of sales can still pressure sentiment.
• Negative Sentiment: The most notable insider sale was by Director Mario Schlosser, who sold 34,120 shares, adding to the perception that leadership is reducing exposure even if the trade was pre-planned.

Institutional Investors Weigh In On Oscar Health

Several hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. boosted its position in shares of Oscar Health by 2.7% in the fourth quarter. Vanguard Group Inc. now owns 20,701,250 shares of the company’s stock worth $297,477,000 after acquiring an additional 540,851 shares during the last quarter. T. Rowe Price Investment Management Inc. lifted its position in Oscar Health by 11.0% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 9,217,816 shares of the company’s stock valued at $132,461,000 after buying an additional 910,320 shares in the last quarter. Morgan Stanley lifted its position in Oscar Health by 42.8% during the fourth quarter. Morgan Stanley now owns 6,814,046 shares of the company’s stock valued at $97,918,000 after buying an additional 2,043,758 shares in the last quarter. Thrive Capital Management LLC lifted its position in Oscar Health by 33.4% during the fourth quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares in the last quarter. Finally, BIT Capital GmbH lifted its position in Oscar Health by 545.0% during the fourth quarter. BIT Capital GmbH now owns 6,186,267 shares of the company’s stock valued at $88,897,000 after buying an additional 5,227,152 shares in the last quarter. 75.70% of the stock is owned by institutional investors and hedge funds.

Oscar Health Company Profile

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.